Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / American Depositary Shares, each representing five-hundred Ordinary Shares
-
Shares outstanding
-
11,387,333
-
Total 13F shares
-
158,075
-
Share change
-
+14,058
-
Total reported value
-
$1,139,856
-
Price per share
-
$7.21
-
Number of holders
-
11
-
Value change
-
+$101,771
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) as of Q3 2025
As of 30 Sep 2025,
KAZIA THERAPEUTICS LTD - American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,075 shares.
The largest 10 holders included
Dauntless Investment Group, LLC, BARCLAYS PLC, Rockefeller Capital Management L.P., UBS Group AG, CITIGROUP INC, RHUMBLINE ADVISERS, MORGAN STANLEY, Arax Advisory Partners, MAI Capital Management, and OSAIC HOLDINGS, INC..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.